IPO Boutique

Aclaris Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Aclaris Therapeutics, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Aclaris TherapeuticsACRS -
NASDAQ
$14.00-$16.00 $11.00 $11.945 million10/7/2015
Jefferies, Citigroup
Co-Manager(s):
William Blair
Health Care
Filing(s):

Filed 2015-08-17
Terms Added 2015-09-25



Aclaris Therapeutics Quote & Chart - Click for current quote - ACRS

About Aclaris Therapeutics (adapted from Aclaris Therapeutics prospectus):
They are a clinical-stage specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated topical drugs to address significant unmet needs in dermatology.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "ACRS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved